GeneTx, Ultragenyx (RARE) Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
Go back to GeneTx, Ultragenyx (RARE) Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.51 +0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.50 | 52 Week High | $117.12 | |||
| Open | $14.79 | 52 Week Low | $46.52 | |||
| Day High | $15.07 | P/E | N/A | |||
| Day Low | $14.07 | EPS | $-1.97 | |||
| Volume | 13,333,782 | |||||
